AstraZeneca is globally withdrawing its COVID-19 vaccine, Covishield, due to a surplus of newer vaccines and declining demand. The company highlights the vaccine's significant role in combating the...

AstraZeneca has withdrawn its COVID-19 vaccine globally due to a surplus of updated vaccines. The company cites a decline in demand for Vaxzevria, which was sold as Covishield in India.

Bharat Biotech assures Covaxin is safe and effective, with no reported side effects like blood clots, unlike Covishield. Developed with safety as priority, it was rigorously tested.

Lupin receives USFDA approval to market a generic version of AstraZeneca's Qtern tablets, a medication for type 2 diabetes. The drug will be manufactured at Lupin's Pithampur facility.

Lupin has received USFDA approval to market a generic medication for type 2 diabetes, a generic equivalent of AstraZeneca's Qtern tablets. The drug will be manufactured at Lupin's Pithampur facility.

S&P Global Ratings says India's sovereign rating could be upgraded within 24 months if the government brings down fiscal deficit to 4% of GDP. The agency expects India's economy to grow at 6.8% in...

Mahindra Group Chairman Anand Mahindra urges Indian companies to increase capital investment to capitalize on growth opportunities in India and globally. He emphasizes the need for a shift in...

India's tyre industry is facing a severe shortage of natural rubber, which could disrupt production. The Automotive Tyre Manufacturers' Association (ATMA) is urging the government to address the...

Franklin Templeton predicts slower equity returns over the next three years, citing high valuations and a shift in earnings growth. Despite this, they expect respectable returns compared to other...

LatentView Analytics completes the acquisition of Decision Point Analysis, a global leader in AI and Revenue Growth Management (RGM) solutions for CPG brands.

S&P Global Ratings says India's sovereign rating could be upgraded within 24 months if the government brings down fiscal deficit to 4% of GDP. The agency expects India's economy to grow at 6.8% in...

Mahindra Group Chairman Anand Mahindra urges Indian companies to increase capital investment to capitalize on growth opportunities in India and globally. He emphasizes the need for a shift in...

India's tyre industry is facing a severe shortage of natural rubber, which could disrupt production. The Automotive Tyre Manufacturers' Association (ATMA) is urging the government to address the...

Lenders of Jaiprakash Associates Ltd (JAL) have rejected the modified one-time settlement proposal submitted by the debt-ridden group. The NCLAT will now proceed with the insolvency proceedings.

Franklin Templeton predicts slower equity returns over the next three years, citing high valuations and a shift in earnings growth. Despite this, they expect respectable returns compared to other...